SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models.

Former US President Joe Biden diagnosed with prostate cancer, a common cancer in men, with various treatment options ...

Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...

Teddi Mellencamp gave an update on her health, including her tumors and her body's response to immunotherapy, during the ...

A promising new study is changing the way doctors think about treating certain cancers. The research focuses on immunotherapy ...

Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...

After treatment with CAR-T cells—immune cells engineered to attack cancer—patients sometimes tell their doctors they feel ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma.

Researchers from MIT and Dana-Farber Cancer ... Immunotherapy treatments such as checkpoint blockade inhibitors, which are designed to help stimulate the body's own T cells to attack tumor cells ...

Cancer immunotherapy has undergone great advancements over the past decade, with T cells emerging as central players in driving antitumor immunity. Despite remarkable clinical successes — particularly ...

1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. 2Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte ...

However, its role in immune regulation and cancer ... cells, CD8+ T cells, neutrophils, and macrophages, further validates its role in the immune microenvironment. In liver hepatocellular carcinoma ...